Daniel Vitt

1.2k citations

45 papers · 906 indexed · h-index 20

Impact in

Molecular Biology
- Biochemical and Molecular Research
- Hedgehog Signaling Pathway Studies
- Epigenetics and DNA Methylation
Epidemiology
- Influenza Virus Research Studies

Papers in ⓘ

Gastroenterology 3
Immunology 8

Co-authors: Gerhard Bringmann (8 shared papers)Johann Leban (9 shared papers)Hella Kohlhof (25 shared papers)Ralf Stowasser (4 shared papers)Markus H. J. Seifert (2 shared papers)Kristina Wolf (2 shared papers)Stefan Strobl (5 shared papers)Evelyn Peelen (12 shared papers)
Journals: Antiviral Research (4 papers)Journal of Crohn s and Colitis (3 papers)Tetrahedron (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of Molecular Modeling (2 papers)
Partner nations: Germany United States Australia

In The Last Decade

Daniel Vitt

42 papers receiving 884 citations

Peers

Countries citing papers authored by Daniel Vitt

Since Specialization

Citations

This map shows the geographic impact of Daniel Vitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Vitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Vitt more than expected).

Fields of papers citing papers by Daniel Vitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Vitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Vitt. The network helps show where Daniel Vitt may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Vitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Vitt Line = papers co-authored together Daniel Vitt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Atropisomer-Selective Ring Cleavage of Helically Distorted, Configuratively Unstable Biaryl Lactones with a Chiral Metallated N -Nucleophile - the Complete PM3 Mechanistic Course and its Video Presentation Journal of Molecular Modeling ·Gerhard Bringmann, Stefan G�ssregen, Daniel Vitt, Ralf Stowasser	1998	93
2	The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance Cellular Microbiology ·Christina Ehrhardt, Andrea Rückle, Eike R. Hrincius, Emanuel Haasbach, Darisuren Anhlan, Katharina Ahmann, Carina Banning, Sarah J. Reiling, Joachim Kühn, Stefan Strobl, Daniel Vitt, Johann Leban, Oliver Planz, Stephan Ludwig	2013	71
3	Virtual high-throughput in silico screening Markus H. J. Seifert, Kristina Wolf, Daniel Vitt	2003	58
4	DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance Oncotarget ·Wolfgang Gruber, Martin Hutzinger, Dominik P. Elmer, Thomas Parigger, Christina Sternberg, Lukasz Cegielkowski, Mirko Zaja, Johann Leban, Susanne Michel, Svetlana Hamm, Daniel Vitt, Fritz Aberger	2016	55
5	Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis Multiple Sclerosis and Related Disorders ·Andreas Muehler, Evelyn Peelen, Hella Kohlhof, Manfred Gröppel, Daniel Vitt	2020	46
6	2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε Amino Acids ·Joachim Bischof, Johann Leban, Mirko Zaja, Arnhild Grothey, Barbara Radunsky, Olaf G. Othersen, Stefan Strobl, Daniel Vitt, Uwe Knippschild	2012	43
7	IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro Viruses ·Friedrich Hahn, Christina Wangen, Sigrun Häge, Antonia Sophia Peter, Gerhard Dobler, Brett L. Hurst, Justin G. Julander, Jonas Fuchs, Zsolt Ruzsics, Klaus Überla, Hans‐Martin Jäck, Roger G. Ptak, Andreas Muehler, Manfred Gröppel, Daniel Vitt, Evelyn Peelen, Hella Kohlhof, Manfred Marschall	2020	41
8	Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC‐202 blocks oncogenic hedgehog‐GLI signaling and overcomes smoothened inhibitor resistance International Journal of Cancer ·Wolfgang Gruber, Elisabeth Peer, Dominik P. Elmer, Christina Sternberg, Suzana Tesanovic, Pedro del Burgo, Sonia Coni, Gianluca Canettieri, Daniel Neureiter, René Bartz, Hella Kohlhof, Daniel Vitt, Fritz Aberger	2017	39
9	Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis Antiviral Research ·Manfred Marschall, Ina Niemann, Karin Kosulin, Anna Bootz, Sabrina Wagner, Thomas Dobner, Thomas Herz, Bernd Krämer, Johann Leban, Daniel Vitt, Thomas Stamminger, Corina Hutterer, Stefan Strobl	2013	39
10	The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus Antiviral Research ·Emanuel Haasbach, Sarah J. Reiling, Christina Ehrhardt, Karoline Droebner, Andrea Rückle, Eike R. Hrincius, Johann Leban, Stefan Strobl, Daniel Vitt, Stephan Ludwig, Oliver Planz	2013	37
11	Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity Antiviral Research ·Corina Hutterer, Jens Milbradt, Stuart T. Hamilton, Mirko Zaja, Johann Leban, Christophe Henry, Daniel Vitt, Mirjam Steingruber, Eric Sonntag, Isabel Zeitträger, Hanife Bahsi, Thomas Stamminger, William D. Rawlinson, Stefan Strobl, Manfred Marschall	2017	32
12	5‐exo or 6‐endo? Exploring Transition State Structures in Cyclizations of 4‐Penten‐1‐oxyl Radicals Angewandte Chemie International Edition in English ·Jens Hartung, Ralf Stowasser, Daniel Vitt, Gerhard Bringmann	1996	31
13	Difluoro-dioxolo-benzoimidazol-benzamides As Potent Inhibitors of CK1δ and ε with Nanomolar Inhibitory Activity on Cancer Cell Proliferation Journal of Medicinal Chemistry ·Julia Richter, Joachim Bischof, Mirko Zaja, Hella Kohlhof, Olaf G. Othersen, Daniel Vitt, Vanessa Alscher, Irmgard Pospiech, Balbina García-Reyes, Sebastian Berg, Johann Leban, Uwe Knippschild	2014	30
14	Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients International Journal of Cancer ·Julia Richter, Kalim Ullah, Pengfei Xu, Vanessa Alscher, Annette Blatz, Christian Peifer, Jakob Halekotte, Johann Leban, Daniel Vitt, Karlheinz Holzmann, Vasiliy А. Bakulev, Lorenzo A. Pinna, Doris Henne‐Bruns, Andreas Hillenbrand, Marko Kornmann, Frank Leithäuser, Joachim Bischof, Uwe Knippschild	2014	29
15	Biaryl hydroxy aldehydes as intermediates in the metal-assisted atropo-enantioselective reduction of biaryl lactones: Structures and aldehyde-lactol equilibria Tetrahedron ·Gerhard Bringmann, Matthias Breuning, H. Endress, Daniel Vitt, Karl Peters, E.‐M. Peters	1998	24
16	The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study Drugs in R&D ·Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel Vitt	2019	23
17	Stereoselective Ring-Opening Reaction of Axially Prostereogenic Biaryl Lactones with Chiral Oxazaborolidines: An AM1 Study of the Complete Mechanistic Course The Journal of Organic Chemistry ·Gerhard Bringmann, Daniel Vitt	1995	23
18	Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects European Journal of Drug Metabolism and Pharmacokinetics ·Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel Vitt	2020	22
19	Human dihydroorotate dehydrogenase inhibitors, a novel approach for the treatment of autoimmune and inflammatory diseases Arzneimittelforschung ·Johann Leban, Daniel Vitt	2011	22
20	The ortho-hydroxy-ortho′-formyl biaryl/lactol equilibrium: Quantumchemical studies on structure and dynamics Tetrahedron ·Gerhard Bringmann, Daniel Vitt, Jürgen Kraus, Matthias Breuning	1998	20

About Daniel Vitt

Daniel Vitt is a scholar working on Gastroenterology, Immunology, Molecular Biology, Computer Graphics and Computer-Aided Design and Genetics, having authored 45 papers that have together received 906 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (8 papers), Axial and Atropisomeric Chirality Synthesis (5 papers), Cytomegalovirus and herpesvirus research (5 papers), Molecular spectroscopy and chirality (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Epigenetics and DNA Methylation (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Molecular Biology (435 citations), Epidemiology (205 citations), Organic Chemistry (168 citations), Immunology (122 citations) and Hepatology (45 citations). Daniel Vitt has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Gerhard Bringmann, Johann Leban, Hella Kohlhof, Ralf Stowasser, Markus H. J. Seifert, Kristina Wolf, Stefan Strobl, Evelyn Peelen, Mirko Zaja and Uwe Knippschild. Their work appears in journals such as Antiviral Research, Journal of Crohn s and Colitis, Tetrahedron, Journal of Medicinal Chemistry and Journal of Molecular Modeling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact